Alina Cummins, PA
Medical · Springfield, MONPI 1851753826
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 264 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,331, 9.6 times the $242 reported in 2021.
Across 264 payments — averaging $24.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$910
- Amgen$830
- Dexcom, Inc.$561
- Abbott$477
- Lilly USA, LLC$440
- Bayer$348
- plus $3K from 31 others
What the payments were for
- Food & beverage$6,384100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $910 |
| Amgen | 33 | $830 |
| Dexcom, Inc. | 47 | $561 |
| Abbott | 17 | $477 |
| Lilly USA, LLC | 23 | $440 |
| Bayer | 10 | $348 |
| Sanofi-aventis U.S. LLC | 9 | $256 |
| Recordati_rare_diseases_inc. | 7 | $235 |
| Kyowa Kirin, Inc. | 7 | $223 |
| Radius Health, Inc. | 9 | $222 |
| Neurocrine Biosciences, Inc. | 2 | $184 |
| Globus Medical | 4 | $149 |
| Chiesi USA, Inc. | 7 | $139 |
| Antares Pharma, Inc. | 8 | $133 |
| Phathom Pharmaceuticals, Inc. | 1 | $124 |
| Insulet Corporation | 5 | $114 |
| Boehringer Ingelheim | 7 | $112 |
| Johnson & Johnson | 1 | $111 |
| Novartis | 6 | $93 |
| Vertex | 1 | $90 |
| Medtronic | 1 | $75 |
| Ascendis Pharma Endocrinology Inc | 3 | $68 |
| Averitas Pharma Inc. | 3 | $65 |
| AstraZeneca | 1 | $60 |
| Corcept Therapeutics | 2 | $53 |
| Pfizer | 3 | $51 |
| Cequr Corporation | 2 | $45 |
| RGH Enterprises LLC | 1 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $27 |
| Intuity Medical Inc | 1 | $24 |
| Alvogen Inc | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Amryt Pharma Holdings Ltd | 1 | $16 |
| AbbVie | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Halozyme Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,384 in reported general payments places this provider in the 85th percentile of 198 medical providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 423 | $498,814 |
| OzempicSemaglutide | 427 | $485,079 |
| Tresiba Flextouch U-200Insulin Degludec | 263 | $282,728 |
| JardianceEmpagliflozin | 234 | $239,770 |
| TrulicityDulaglutide | 140 | $177,593 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 81 | $162,860 |
| FarxigaDapagliflozin Propanediol | 187 | $145,321 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 128 | $131,936 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 109 | $127,115 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 89 | $77,870 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 276 | $57,826 |
| ForteoTeriparatide | 11 | $54,928 |
| Novolog FlexpenInsulin Aspart | 163 | $52,493 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 61 | $52,065 |
| Humalog Kwikpen U-100Insulin Lispro | 83 | $48,688 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Forteo, Humalog | $440 | $737,124590 claims |
| Novo NordiskOzempic, Rybelsus | $910 | $524,539450 claims |
| Boehringer IngelheimJardiance, Trijardy Xr, Tradjenta | $112 | $253,815259 claims |
| AstraZenecaFarxiga | $60 | $145,321187 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $256 | $127,115109 claims |
| Radius Health, Inc.Tymlos | $222 | $32,01312 claims |
| Johnson & JohnsonInvokana | $111 | $30,35329 claims |
| AmgenProlia | $830 | $19,41011 claims |
| AbbVieSynthroid | $16 | $10,903152 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $6,013719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 198 medical providers in Missouri.
Other medical in Springfield
- Melanie ChisamSpringfield$92K
- Dustin BartlettSpringfield$21K
- Amberly EversoleSpringfield$4K
- Kara WalkerSpringfield$4K
- Amber BeckSpringfield$2K
- Kaitlin FosterSpringfield$2K
- Jessica SpencerSpringfield$1K
- Emily JensenBowling Green$51K
- Sarah WilmsmeyerChesterfield$22K
- Amy MosmanSaint Louis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.